Back to Blog

Guidance Document

Electronic Submission Template for Medical Device 510(k) Submissions

Guidance for Industry and Food and Drug Administration Staff

Document issued on October 2, 2023.

Document originally issued on September 22, 2022.

Docket Number: FDA-2021-D-0872

Issued by:

Center for Devices and Radiological Health

Center for Biologics Evaluation and Research

This guidance provides the standards for the submission of premarket notification (510(k)) submissions by electronic format, a timetable for establishment of these standards, and criteria for waivers of and exemptions from the requirements to meet a statutory requirement. This guidance is also intended to represent one of several steps in meeting FDA's commitment to the development of electronic submission templates to serve as guided submission preparation tools for industry to improve submission consistency and enhance efficiency in the review process. As of October 1, 2023, FDA will require that 510(k) electronic submissions be provided as described in this guidance.

Download the Final Guidance Documents

Reference: FDA

Share:

Continue Exploring

These resources provide scientific background and general education. They do not establish Medora's performance or OraDx AI's clinical validity, and they are not individual medical advice.

Biomedisca

Building a Healthier World

Biomedisca develops Medora, an investigational chairside screening test, and OraDx AI, an AI-assisted biomedical research platform, with a shared focus on oral–systemic health.

Resources

Copyright © 2026 Biomedisca, Inc., CA, USA. All rights reserved.